Viewing Study NCT02442206


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-01-13 @ 3:01 PM
Study NCT ID: NCT02442206
Status: COMPLETED
Last Update Posted: 2019-01-03
First Post: 2015-05-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD Patients
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-05-18
Start Date Type: ACTUAL
Primary Completion Date: 2017-04-20
Primary Completion Date Type: ACTUAL
Completion Date: 2017-05-15
Completion Date Type: ACTUAL
First Submit Date: 2015-05-06
First Submit QC Date: None
Study First Post Date: 2015-05-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-04-27
Results First Submit QC Date: None
Results First Post Date: 2018-12-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-12-10
Last Update Post Date: 2019-01-03
Last Update Post Date Type: ACTUAL